Stockreport

ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF Management expects Rare Disease to represent about 60% of 2026 sales, signaling a continued shift toward higher-margin therapies led by Cortrophin Gel. That pivot come [Read more]